|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Depreciation and amortization, excluding amortization of deferred certification and dry dock costs | |||||
| Amortization of deferred certification and dry dock costs | |||||
| Total depreciation and amortization | |||||
| Long-lived asset impairment | |||||
| Deferred certification and dry dock costs | |||||
| Payment of earnout consideration | |||||
| Change in fair value of contingent consideration | |||||
| Amortization of debt discount | |||||
| Amortization of debt issuance costs | |||||
| Share-based compensation | |||||
| Deferred income taxes | |||||
| (Gain) loss on disposition of assets, net | |||||
| Loss on extinguishment of long-term debt | |||||
| Losses related to convertible senior notes | |||||
| Unrealized foreign currency losses | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Other current assets | |||||
| Income tax receivable, net of income tax payable | |||||
| Accounts payable and accrued liabilities | |||||
| Deferred recertification and dry dock costs, net | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of assets | |||||
| Proceeds from insurance recoveries | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from senior notes, net of discount | |||||
| Payments related to convertible senior notes | |||||
| Repayment of MARAD Debt | |||||
| MARAD Debt (matures February 2027) | |||||
| Total repayment of MARAD Debt | |||||
| Proceeds from settlement of capped calls | |||||
| Debt issuance costs | |||||
| Repurchases of common stock | |||||
| Payments related to tax withholding for share-based compensation | |||||
| Proceeds from issuance of ESPP shares | |||||
| Payment of earnout consideration | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents: | |||||
| Balance, beginning of year | |||||
| Balance, end of year | |||||
Loading...